共 187 条
[1]
Kaufmann M(2012)Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer Ann Surg Oncol 19 1508-1516
[2]
von Minckwitz G(2014)Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients J Breast Cancer 17 40-46
[3]
Mamounas EP(2016)The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival Breast 29 181-185
[4]
Cameron D(2012)Defining the benefits of neoadjuvant chemotherapy for breast cancer J Clin Oncol 30 1747-1749
[5]
Carey LA(2009)Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel J Clin Oncol 27 4701-4708
[6]
Cristofanilli M(2017)Long-term prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype J Clin Oncol 35 1049-1060
[7]
Kim KI(2013)An international Ki67 reproducibility study J Natl Cancer Inst 105 1897-1906
[8]
Lee KH(2013)Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial Ann Oncol 24 2786-2793
[9]
Kim TR(2013)Ki67 measured after neoadjuvant chemotherapy for primary breast cancer Clin Cancer Res 19 4521-4531
[10]
Chun YS(2012)Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review Breast Cancer Res Treat 132 895-915